Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Ireland study to explore immunology of bovine TB
An estimated 30-40 per cent of TB-infected herds in Ireland experience a repeated breakdown within three years.
The project will focus on the role of nutrition and Vitamin D in disease recurrence.

Researchers across Ireland have joined forces in a first-of-its-kind study to better understand the immunology of bovine TB.

Scientists from The Institute for Global Food Security (IGFS), the Agri-Food and Biosciences Institute (AFBI) and University College Dublin (UCD) will explore how nutrition and Vitamin D might influence animals' immune response and disease outcomes on farms that experience recurring infection.

Project lead Dr Kieran Meade, from the UCD School of Agriculture and Food Science, said: “Multiple studies now point to an animal-specific issue that prevents current diagnostic tests from identifying all truly infected cattle, and these cattle act as a reservoir of persistent infection.

"The weight of evidence from the human literature and our exciting preliminary data suggests that Vitamin D status will have a decisive impact on livestock immunity to diseases including TB.”

Owing to a relapse of infection on farms on both sides of the Irish border, it is thought that TB-infected herds have a 30–40 per cent probability of experiencing a repeated breakdown within three years. Experts say that to eradicate bTB, the UK, Ireland, and the EU must intensify focus on the causes of recurrent infection.

Professor Ilias Kyriazakis of IGFS, who has a background in veterinary medicine, said: “Queen’s has previously associated Vitamin D status of livestock with their immune response to a variety of pathogens, and this exciting collaboration offers us the opportunity to build on our previous research.”

The researchers aim to identify the host factors contributing to the relapse of infections in specific cattle or herds, and use this knowledge to inform strategies for TB eradication, both in NI and ROI.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
Applications open for BEVA Back in the Saddle

The British Equine Veterinary Association (BEVA) has opened applications for its 'Back in the Saddle' coaching programme.

The online scheme offers structured group coaching for members wanting to reflect on their career path and regain clarity. Members may be returning to work after leave, uncertain about next steps or reassessing direction.

Attendees will benefit from impartial guidance and practical tools to support their professional development. Members are encouraged to take a 'proactive, future-focused approach' to their careers.

The sessions, taking place on Wednesdays from 7.30pm-9pm, are open to BEVA members with more than five years' experience. The first session takes place on Wednesday, 3 June 2026.

Applications will close on Wednesday, 27 May 2026.